MSCs & Precision Medicine- Mining a “Galaxy” of Answers for the “Ultimate” Questions August 27, 2021 Cell Therapy, MSCs & Characterization
hUC-MSCs Are Unique: Are the Biomaterials, Bioprocesses, & Clinical Product Developers Now “in… July 27, 2021 Cell Therapy, MSCs & Characterization
It’s Not Rocket Science – “MSC-EVs” Have the Right Stuff July 14, 2021 Biomanufacturing, Cell Therapy, EVs & Exosomes, MSCs & Characterization
Environmental Analysis of Therapeutic hMSC Manufacturing: A Comparison of Multiple Bioprocess Systems June 08, 2021 Biomanufacturing, Quality & Regulatory
Identify & Define Your Cell Therapy’s Biomanufacturing Approach for Critical Process… April 27, 2021 Biomanufacturing, Quality & Regulatory
Critical Quality Attributes (CQAs): Know Their Importance & Limitations in Product & Process… April 27, 2021 Biomanufacturing, Quality & Regulatory
“Known Unknowns” Affect Critical Process Parameters & Critical Quality Attributes in the… April 22, 2021 Biomanufacturing, Quality & Regulatory
Industry KOL Interview Series with Dr. Christian van den Bos February 18, 2021 Cell Therapy, MSCs & Characterization
MSC KOL Interview: Tackling MSC EV Drug Delivery & Biomanufacturing Challenges with Steven Jay January 20, 2021 EVs & Exosomes
